Average Co-Inventor Count = 3.52
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Pharmaceuticals, Inc. (73 from 576 patents)
2. Incyte Corporation (14 from 669 patents)
3. Incyte Genomics, Inc. (10 from 163 patents)
4. Other (2 from 832,912 patents)
5. Inctye Pharmaceuticals, Inc. (1 from 2 patents)
100 patents:
1. 9885717 - Methods for detecting expression levels of human signal peptide-containing proteins (HSPP)
2. 9512234 - Methods for treating colon cancer and inflammation associated with overexpression of human signal peptide-containing proteins
3. 9102745 - Antibodies which bind to signal peptide-containing molecules
4. 8716445 - Compositions comprising signal peptide-containing proteins
5. 8206947 - Human transmembrane proteins
6. 8153398 - Polynucleotides encoding signal peptide-containing molecules
7. 7396663 - Isolated polynucleotide encoding a G-protein coupled receptor
8. 7321023 - SP16 protein
9. 7112426 - Human cAMP-dependent protein kinase beta-catalytic subunit
10. 7022507 - Isolated polynucleotide encoding a human PSST subunit of the NADH:ubiquinone oxidoreductase complex
11. 6927056 - Proteases
12. 6916609 - Two new human DnaJ-like proteins
13. 6913891 - Human myeloid terminal differentiation response gene
14. 6808895 - DNA encoding oxidoreductase and polypeptide encoded thereby
15. 6500938 - Composition for the detection of signaling pathway gene expression